Steris (NYSE:STE) reported quarterly earnings of $1.90 per share which missed the analyst consensus estimate of $1.91 by 0.52 percent. This is a 7.95 percent increase over earnings of $1.76 per share from the same period last year.
Sanofi, Provention Bio Ink Co-Promotion Pact For Type 1 Diabetes Treatment Candidate
Provention Bio Inc (NASDAQ:PRVB) has entered into a co-promotion agreement with Sanofi SA (NASDAQ:SNY) to launch Provention’s lead investigational candidate, teplizumab, to delay…
